Find
News Releases
= add release to Briefcase
| All Releases | |||
|---|---|---|---|
 |
2006 NBA Champion Alonzo Mourning Raises Awareness About Kidney Disease Jul 6, 2006 |
10.4 KB |
|
|
BRIDGEWATER, N.J., July 6, 2006 /PRNewswire via COMTEX News Network/ -- As a legend on the basketball court, 2006 NBA Champion Alonzo Mourning is focused on the task at hand -- the game. Off the court, he is just as determined to be proactive in taking care of his health while encouraging others to do the same, because he himself had a kidney trans... |
|||
|
Janssen Pharmaceutica Announces Collaboration with Vertex Pharmaceuticals to Develop and Commercialize VX-950 for Treatment of Hepatitis C Jun 30, 2006 |
9.5 KB |
|
|
Johnson & Johnson (NYSE: JNJ) announced today that Janssen Pharmaceutica N.V., a Johnson & Johnson company, has entered into a collaboration with Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) to develop and commercialize Vertex's investigational hepatitis C virus (HCV) protease inhibitor, VX-950. Under the agreement, Janssen will have exclusiv... |
|||
|
Johnson & Johnson to Acquire Pfizer Consumer Healthcare; Combination Creates World's Premier Consumer Health Care Company Jun 26, 2006 |
10.0 KB |
|
|
Johnson & Johnson (NYSE: JNJ), the world's most comprehensive and broadly based manufacturer of health care products, today announced that it has entered into a definitive agreement to acquire Pfizer Consumer Healthcare for $16.6 billion in cash. The Johnson & Johnson Board of Directors has given approval to the transaction. Closing is subject ... |
|||
|
American Optometric Association Awards ACUVUE ADVANCE, ACUVUE OASYS Brands With Seal of Acceptance for UV Absorbing Contact Lenses Jun 23, 2006 |
9.8 KB |
|
|
Vistakon(R), Division of Johnson & Johnson Vision Care, Inc., today announced that its ACUVUE(R) ADVANCE(TM) with HYDRACLEAR(TM), ACUVUE ADVANCE(TM) for ASTIGMATISM, and ACUVUE OASYS(TM) with HYDRACLEAR(TM) PLUS Brand Contact Lenses are the first contact lenses to receive a Seal of Acceptance for Ultraviolet Absorbing Contact Lenses from the Americ... |
|||
|
Johnson & Johnson to Participate in Goldman Sachs Conference Jun 8, 2006 |
5.7 KB |
|
|
NEW BRUNSWICK, N.J., June 8, 2006 /PRNewswire-FirstCall via COMTEX News Network/ -- Johnson & Johnson will participate in the Twenty-Seventh Annual Goldman Sachs Healthcare Conference on Thursday, June 15 at The Ritz-Carlton, Laguna Niguel in Dana Point, California. Christine Poon, Vice Chairman and Worldwide Chairman, Medicines & Nutritionals, wi... |
|||
|
Update On Regulatory Filing Plans for Investigational Compound Trabectedin in Soft Tissue Sarcoma Jun 1, 2006 |
8.9 KB |
|
|
RARITAN, N.J. and MADRID, Spain, June 1, 2006 /PRNewswire-FirstCall via COMTEX News Network/ -- Johnson & Johnson Pharmaceutical Research & Development, L.L.C. (J&JPRD) and PharmaMar today provided an update on plans for the regulatory filings of trabectedin, an investigational treatment for soft tissue sarcoma (STS), which the two companies are d... |
|||
|
Clinical Study of Investigational Drug Paliperidone ER Demonstrated Efficacy and Tolerability in the Treatment of Patients With Schizophrenia May 23, 2006 |
10.1 KB |
|
|
TORONTO, May 23, 2006 /PRNewswire via COMTEX News Network/ -- A multinational, multicenter phase III study presented today at the 159th annual meeting of the American Psychiatric Association showed that the investigational, once-a-day oral medication, paliperidone extended release (ER) tablets, was effective in significantly reducing positive and ... |
|||
|
Physicians Now Have a New Treatment Option for Patients With a Common Vascular Disease Affecting the Legs May 16, 2006 |
8.8 KB |
|
|
WARREN, N.J., May 16, 2006 /PRNewswire via COMTEX News Network/ -- Patients with vascular disease affecting the legs now have a new treatment option. Cordis Endovascular, a division of Cordis Corporation, today announced the availability of the S.M.A.R.T.(R) Stent for primary stenting in the iliac artery, which allows blood flow to the legs. It is... |
|||
|
District Court Issues Two Decisions Regarding Patent Litigation Between Cordis Corporation and Boston Scientific May 11, 2006 |
6.9 KB |
|
|
MIAMI, May 11, 2006 /PRNewswire via COMTEX News Network/ -- A U.S. District Court Judge in Wilmington, Del. issued two decisions today about post-trial motions related to jury verdicts last year in patent litigation between Cordis Corporation, a Johnson & Johnson company, and Boston Scientific. In the first decision, Judge Sue Robinson upheld ... |
|||
|
Johnson & Johnson to Participate in the Banc of America Securities Health Care Conference 2006 May 11, 2006 |
5.7 KB |
|
|
NEW BRUNSWICK, N.J., May 11, 2006 /PRNewswire-FirstCall via COMTEX News Network/ -- Johnson & Johnson will participate in The Banc of America Securities Health Care Conference 2006 on Wednesday, May 17 at The Four Seasons Hotel in Las Vegas, Nevada. Michael J. Dormer, Worldwide Chairman, Medical Devices Group, will be representing the Company in a... |
|||
|
Pharmaceutical Operating Companies of Johnson & Johnson Continue Patient Assistance for Eligible Medicare Beneficiaries May 10, 2006 |
9.0 KB |
|
|
NEW BRUNSWICK, N.J., May 10, 2006 /PRNewswire-FirstCall via COMTEX News Network/ -- The pharmaceutical operating companies of Johnson & Johnson announced today a three-part program to assist low-income Medicare beneficiaries. * The companies will continue to offer their patient assistance programs (PAPs) to seniors and disabled patients... |
|||
|
ETHICON, Inc. Completes Acquisition of Vascular Control Systems, Inc. May 9, 2006 |
6.2 KB |
|
|
SOMERVILLE, N.J., May 9, 2006 /PRNewswire via COMTEX News Network/ -- ETHICON, Inc. today announced it has acquired Vascular Control Systems, Inc. (http://www.vascularcontrol.com), a privately held company focused on developing medical devices to treat fibroids and to control bleeding in obstetric and gynecologic applications. Terms of the transac... |
|||
|
Janssen-Cilag Submits Marketing Authorization Application in Europe for New Treatment for Schizophrenia May 5, 2006 |
7.5 KB |
|
|
BEERSE, Belgium, May 5, 2006 /PRNewswire-FirstCall via COMTEX News Network/ -- Janssen-Cilag International NV, has submitted a Marketing Authorization Application to the European Medicines Evaluations Agency for Paliperidone Prolonged Release Tablets, an investigational prolonged release, once daily, oral medication for the treatment of schizophre... |
|||
|
Johnson & Johnson to Participate in Morgan Stanley Conference Apr 27, 2006 |
5.7 KB |
|
|
NEW BRUNSWICK, N.J., April 27, 2006 /PRNewswire-FirstCall via COMTEX News Network/ -- Johnson & Johnson will participate in The Morgan Stanley Fourth Annual Global Healthcare Unplugged Conference on May 3rd at the Mandarin Oriental hotel in Miami, Florida. Nicholas J. Valeriani, Worldwide Chairman, Cardiovascular Devices & Diagnostics, will repres... |
|||
|
Johnson & Johnson Announces Dividend Increase of 13.6% Apr 27, 2006 |
7.1 KB |
|
|
NEW BRUNSWICK, N.J., April 27, 2006 /PRNewswire-FirstCall via COMTEX News Network/ -- Johnson & Johnson today announced that its Board of Directors has declared a 13.6% increase in the quarterly dividend rate, from $.33 per share to $.375 per share. The increase was announced this morning at the Annual Shareholders Meeting in New Brunswick, NJ. ... |
|||
|
Johnson & Johnson to Host Annual Meeting of Shareholders Apr 24, 2006 |
5.8 KB |
|
|
NEW BRUNSWICK, N.J., April 24, 2006 /PRNewswire-FirstCall via COMTEX News Network/ -- Johnson & Johnson will host its Annual Meeting of shareholders at 10 a.m. (Eastern Daylight Savings Time) on Thursday, April 27, at the Hyatt Regency Hotel in New Brunswick, New Jersey. Investors and other interested parties may access the meeting by visiting... |
|||
|
Johnson & Johnson Reports 2006 First-Quarter EPS Rose 17.0% on Sales Increase of 1.2% Apr 18, 2006 |
14.3 KB |
|
|
NEW BRUNSWICK, N.J., April 18, 2006 /PRNewswire-FirstCall via COMTEX News Network/ -- Johnson & Johnson today announced sales for the first quarter of $13.0 billion, an increase of 1.2% as compared to the first quarter of 2005. Operational growth was 3.5% with a negative currency impact of 2.3%. Domestic sales were up 1.6%, while international sal... |
|||
|
Johnson & Johnson to Host Analyst Conference Call on First-Quarter Results Apr 11, 2006 |
5.8 KB |
|
|
NEW BRUNSWICK, N.J., April 11, 2006 /PRNewswire via COMTEX News Network/ -- Johnson & Johnson will host a conference call for financial analysts at 8:30 a.m. Eastern Daylight Savings Time on Tuesday, April 18, 2006, to review first-quarter results. Robert J. Darretta, Vice Chairman and Chief Financial Officer, and Louise Mehrotra, Vice President, ... |
|||
|
Ortho-Clinical Diagnostics Issues a Voluntary Product Recall for VITROS(R) Immunodiagnostic Products Signal Reagent Mar 31, 2006 |
||
|
RARITAN, N.J., March 31, 2006 /PRNewswire via COMTEX News Network/ -- Ortho-Clinical Diagnostics, Inc., a Johnson & Johnson company, has initiated a nationwide voluntary product recall of a reagent used with its VITROS Immunodiagnostic ECi/ECiQ laboratory test system because the reagent may produce inaccurate tests results in some cases. This reag... |
|||
|
Johnson & Johnson Presents $100,000 Grant for SF Disaster Preparedness & Neighborhood Emergency Response Training (NERT) Program Mar 28, 2006 |
8.6 KB |
|
|
SAN FRANCISCO, March 28, 2006 /PRNewswire-FirstCall via COMTEX News Network/ -- Johnson & Johnson today announced it is awarding a grant of $100,000 to the City of San Francisco for emergency preparedness, as the City readies for the San Francisco Rising 1906 Earthquake Centennial Commemoration on April 18. Johnson & Johnson's response ... |
|||
= add release to Briefcase
